Download full report with analyst certification and important disclosures
Jan 26 2023, 07:15 GMT
CVS Group
H1 trading statement reflects strong growth and is in line with forecasts
- Sectors : Pharma and healthcare
- Companies : CVS Group
DAVY VIEW
In its H1 trading statement to December 31st, CVS has indicated that revenue and earnings growth are strong and in line with our H1 forecasts. The outlook for trading in FY2023 is reassuring, and we will be leaving our forecasts unchanged. CVS continues to deliver strong organic growth and has balance sheet capacity.
